Life Sciences Market Research Reports

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 01 Feb 2013  |  North America  |  Economic and Databases

    Decision Support Database - Burden Of Disease And Conditions

    Burden of Disease or Conditions Decision Support Database provides information on exhaustive list of Measurements on Incidence, Prevalence and Mortality for different types of Communicable and Non Communicable Disease.

    $1,500.00
  2. 23 Jan 2013  |  North America  |  Market Research

    Analysis of the European HIV Drugs Market

    Increasing Adoption of Oral Combination-pills for Treatment Boosts Market Growth

    Dyslipidemia exists in many forms and is prevalent in developed regions. Although many patients with moderately elevated lipids are well served by available therapies, there is a significant patient population for whom these therapies are inappropriate or inadequate, thereby prompting development of innovative therapies to fill the gaps. This res...

    $4,950.00
  3. 23 Jan 2013  |  South Asia, Middle East & North Africa  |  Market Research

    Overview of the In-vitro Diagnostics Market in India

    This research service provides a detailed analysis of the in-vitro diagnostics market in India. It quantifies the market size, provides insight into the disease burden of India, and examines market dynamics from 2011 to 2018. It also provides an in-depth analysis of the competitive environment through analysis of the competitive structure, the diag...

    $4,950.00
  4. 04 Jan 2013  |  North America  |  Market Research

    Analysis of the U.S. Breast Imaging Systems Market

    A Guide to One of Medical Imagings Key Multi-modality Hubs

    This research service evaluates the U.S. breast imaging systems market during the 2008 to 2016 time period. It provides analyses of the X-ray mammography, breast ultrasound, breast MRI, and molecular breast imaging (MBI) market segments at the total market and individual segment and sub-segment levels. Content in this research service includes mark...

    $4,950.00
  5. 20 Nov 2012  |  North America  |  Market Research

    The U.S. Health Information Exchange Market

    A Comprehensive Guide to Market Dynamics, Technology Vendors, and Future Trends

    This study provides a roadmap for understanding health information exchange. We provide an in-depth overview of the technical aspects of health information exchange (HIE), review major government initiatives driving health information exchange efforts across the U.S.,  define and describe the major market segments and subsegments, and look at rece...

    $4,950.00
  6. 15 May 2012  |  North America  |  Market Research

    Mölnlycke Health Care—Company Profile

    This market insight provides an overview of Mölnlycke Health Care. The Mölnlycke company was established in 1849 by G.F. Henning as primarily a textile manufacturer. In 1997, Mölnlycke Health Care came in to existence when Nordic Capital acquired the medical devices segment of SCA. The company is currently owned by Investor AB and has seen stea...

    $1,500.00